Related Experiment Videos
Popliteal lymph node assay: facts and perspectives.
Guillaume Ravel1, Jacques Descotes
1MDS Pharma Services, 69210 Saint-Germain s/l'Arbresle, France. guillaume.ravel@mdps.com
Journal of Applied Toxicology : JAT
|June 30, 2005
Summary
The popliteal lymph node assay (PLNA) detects drug-induced immune reactions. Refinements improve its ability to predict sensitization and autoimmune responses, though validation and mechanistic understanding are ongoing challenges.
Area of Science:
- Immunotoxicology
- Pharmacology
- Drug Safety Assessment
Background:
- The popliteal lymph node assay (PLNA) investigates immune-mediated adverse drug effects.
- It hypothesizes a mechanism similar to graft-versus-host reactions.
- Direct PLNA measures lymph node changes after compound injection.
Purpose of the Study:
- To refine the PLNA for improved prediction of drug-induced sensitization and autoimmunity.
- To explore alternative PLNA protocols for enhanced predictability.
- To clarify the assay's utility in distinguishing sensitization from autoimmune reactions.
Main Methods:
- Direct PLNA: measuring popliteal lymph node weight/cellularity.
- Modified PLNA protocols: enzyme inducers, CD4(+) T cell depletion, secondary PLNA, adoptive PLNA, reporter antigens (TNP-Ficoll, TNP-ovalbumin).
- Analysis of histological examination, lymphocyte subset analysis, and cytokine fingerprinting.
Main Results:
- Most drugs positive in direct PLNA are associated with drug hypersensitivity syndrome in patients.
- A small validation study showed consistent results for direct PLNA.
- Refined methods aim to improve prediction of sensitization versus autoimmunity.
Conclusions:
- The PLNA is a valuable tool for detecting potential sensitization and autoimmune reactions.
- Further validation and mechanistic studies are crucial for optimizing PLNA protocols.
- Clarifying PLNA's role in predicting distinct immune responses is essential for drug safety.